Shuttle Pharmaceuticals Holdings (SHPH) Intangibles (2025 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Intangibles came in at $9.2 million in Q1 2026, down 8.62% quarter-over-quarter from $10.1 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Intangibles (2025 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Intangibles history runs 2 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- On a quarterly basis, Intangibles changed N/A year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $10.1 million, changed N/A from the prior year.
- Intangibles fell to $9.2 million in Q1 2026 per SHPH's latest filing, from $10.1 million in the prior quarter.
- Across five years, Intangibles topped out at $10.1 million in Q4 2025 and bottomed at $9.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 9.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.24 Mn |
| Dec 31, 2025 | 10.12 Mn |